The surge of companies adding cryptocurrencies to their balance sheets may be hitting a plateau, according to Galaxy Digital ...

Palantir's moonshot is paying off with ETF tailwinds. A bunch of thematic and innovation-themed ETFs are bullish, and they're ...

Vertex stock falls after pain drug VX-993 fails Phase 2 trial, despite better-than-expected Q2 earnings and strong cystic ...

Analysts have provided Horace Mann Educators with 3 ratings, resulting in a consensus rating of Buy. The average one-year ...

Analysts are estimating that Jack In The Box will report an earnings per share (EPS) of $1.16. Investors in Jack In The Box ...

Honest Co ranks higher than its peer in terms of revenue growth and gross profit margin. However, it lags behind in terms of ...

Analysts are estimating that Herbalife will report an earnings per share (EPS) of $0.51. Investors in Herbalife are eagerly ...

In connection with earnings, Vertex announced topline results from the Phase 2 study evaluating the safety and efficacy of VX ...

Inspire Medical stock falls as Q2 earnings beat is overshadowed by guidance cut and slower U.S. rollout of its newly approved ...

Shift4 Payments (FOUR) stock falls on lower-than-expected Q2 results. Revenue growth of 17% missed estimate, adjusted EPS ...

ZetaChain's (CRYPTO: ZETA) latest integration with the Sui (CRYPTO: SUI) blockchain could bring real capital flows and ...

Axon Enterprise Inc. (NASDAQ: AXON) stock surged on strong Q2 results and raised revenue guidance. Multiple analysts raised ...